Free Trial

Citius Pharmaceuticals (CTXR) Earnings Date, Estimates & Call Transcripts

Citius Pharmaceuticals logo
$0.83 +0.01 (+1.21%)
As of 02:24 PM Eastern

Citius Pharmaceuticals Earnings Summary

Upcoming Q2
Earnings Date
May. 13Estimated
Consensus EPS
(Feb. 14)
-$1.25
Actual EPS
(Feb. 14)
-$1.30 Missed By -$0.05

Citius Pharmaceuticals posted Q1 2025 earnings on February 14, 2025, reporting an EPS of -$1.30, which missed analysts' consensus estimates of -$1.25 by $0.05. With a trailing EPS of $0.00, Citius Pharmaceuticals' earnings are expected to grow next year, from ($4.50) to $1.25 per share.

Q1 2025 Earnings Resources

CTXR Upcoming Earnings

Citius Pharmaceuticals' Q2 2025 earnings is scheduled for Tuesday, May 13, 2025, with a conference call scheduled on Monday, May 12, 2025 at 12:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Citius Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Citius Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CTXR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Citius Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.05-$0.05-$0.05
Q2 20251-$0.05-$0.05-$0.05
Q3 20251-$0.04-$0.04-$0.04
Q4 20251-$0.04-$0.04-$0.04
FY 20254($0.18)($0.18)($0.18)

Citius Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/13/2025
(Estimated)
--------
2/14/2025Q1 2025-$1.25-$1.30 -$0.05-$1.30--
8/12/2024--$1.25-$1.50 -$0.25-$0.06--
5/14/2024Q2 2024-$1.50-$1.25+$0.25-$0.05--
2/14/2024Q1 2024$3.25-$1.50 -$4.75-$0.06--
12/29/2023Q4 2023-$0.50-$1.75 -$1.25-$0.07--
8/14/2023Q3 2023-$1.50-$1.50--$0.06--
5/12/2023Q2 2023-$1.00-$1.75 -$0.75-$0.07--

Citius Pharmaceuticals Earnings - Frequently Asked Questions

Citius Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on CTXR's earnings history.

In the previous quarter, Citius Pharmaceuticals (NASDAQ:CTXR) missed the analysts' consensus estimate of ($1.25) by $0.05 with a reported earnings per share (EPS) of ($1.30). Learn more on analysts' earnings estimate vs. CTXR's actual earnings.

Citius Pharmaceuticals (NASDAQ:CTXR) has a recorded net income of -$39.14 million. CTXR has generated $0.00 earnings per share over the last four quarters.

Citius Pharmaceuticals's earnings are expected to grow from ($4.50) per share to $1.25 per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:CTXR) was last updated on 4/23/2025 by MarketBeat.com Staff
From Our Partners